Agilent Reports 10% Revenue Jump in Q3
Agilent Technologies (NYSE:A), a global leader in laboratory instruments and scientific solutions for life sciences and diagnostics, released its Q3 fiscal 2025 results on Aug. 27, 2025. The company delivered revenue of $1.74 billion, coming in over its own projected revenue guidance and achieving a 10.1% increase over the prior year period. Non-GAAP earnings per share were $1.37, which was at the high end of management’s forecast and matched analyst expectations. Profitability also improved compared to last year.
However, operating margins narrowed in all business units due to increased costs, including tariffs and higher operating expenses. Overall, the quarter demonstrated broad-based growth across the company, with management responding by raising both annual revenue and profit forecasts for fiscal 2025.
Agilent Technologies provides analytical instruments, software, and consumables for laboratories worldwide. Its customers work primarily in life sciences, pharmaceutical research, diagnostics, food testing, and chemical analysis. The company's products help scientists analyze everything from new medicines to food safety and environmental samples. Its technology range includes mass spectrometry systems, which identify molecular structures; liquid chromatography platforms, which separate chemical mixtures; and automated pathology diagnostics used in hospitals.
Source Fool.com
Agilent Technologies Inc. Stock
We see a rather positive sentiment for Agilent Technologies Inc. with 14 Buy predictions and 2 Sell predictions.
With a target price of 127 € there is a slightly positive potential of 5.43% for Agilent Technologies Inc. compared to the current price of 120.46 €.
